Anlong Bio Announces Grand Opening of R&D and GMP Production Facilities in Shunyi, Beijing

Recently, Anlong Biopharmaceutical Co., Ltd (Anlong Bio, or the Company), a gene therapy company in China, announced its new 55,000 sqft R&D and GMP production facility in Beijing Shunyi Zhongguancun Medical Transformation Center.

Since its establishment in 2019, Anlong Bio has achieved remarkable success. Aligning with its scientific insight and driving force in R&D, Anlong Bio strives to develop the most advanced gene therapy and nucleic acid drugs. The Company has collaborated with Tsinghua University, Capital Medical University, and other universities in establishing the Anlong Bio Gene Therapy R&D Center. The R&D Center is equipped with a 55,000 sqft R&D and GMP production facilities located i n the Zhongguancun Medical Transformation Center in Shunyi, Beijing. As a result, Anlong Bio has unique advantages in gene therapy and nucleic acid drug design, preclinical research, CMC development, GMP production, virus manufacturing process, large-scale production, and cost control. Meanwhile, Anlong Bio has integrated abundant rare disease resources in China. It has built a close relationship with the nation's largest rare disease organization,the Chinese Organization for Rare Disorders, to lay the foundation for future product development and listing.

Shunyi District Mayor Zongyuan Gong visiting Anlong Manufacturing Site on Aug 2021

As a benchmark enterprise in the technology innovation industry of Shunyi District, Anlong Bio has attracted the attention of the district government. A few days ago, Zongyuan Gong, deputy secretary and mayor of Shunyi District, Beijing, came to the Zhongguancun Medical Engineering Health Industrialization Base and visited Anlong Bio to understand the Company's business scope, management state, development needs, etc. He noted that it is necessary to provide good services with heart and emotion, optimize the business environment, improve basic supporting facilities, and achieve a win-win situation between corporate development and regional economic and social development. He pointed out that it is necessary to enhance the service of Shunyi-settled enterprises further, strengthen the policy research support, and identify unmet needs. As a result, the enterprises can invest peacefully and develop wholeheartedly. Through effective promotion, guidance, and assistance, a high-quality production capacity and innovation highlights can help promote high-quality development in the pharmaceutical industry. Weimin Zhao, Deputy District Mayor and Director of Shunyi Branch of the Municipal Public Security Bureau, Fenghui Yang, Vice Chairman of the District Political Consultative Conference and Director of the District Investment Promotion Center, Xiaojun Zhang, Secretary of the Party Leadership Group and Director of the District People’s Government Office, Yongzhi Huang, Director of the Management Committee of Beijing Linkong Economic Core District, and District

Jingxin Bureau Director Xiongjing Lan and Director Jianguo Zhang of the Management Committee of Zhongguancun Shunyi Park attended the event. Dr. Chunlin Zhao, the chairman and CEO of Anlong Bio has introduced the Company's business scope, business states, and development needs to the district government leaders. In addition, he accompanied them to visit the workshops of upstream cell culture, downstream stock solution purification, process development laboratory, and quality control laboratory. Anlong Bio attaches importance to the perfect combination of overseas returnees and local experience in terms of talent introduction. The team possesses experience in high-end scientific research, multinational companies, entrepreneurship, and investment. Dr.Wei Ding( Deputy Dean of the School of Basic Medicine, Capital Medical University), Dr. Yongjun Wang(Tiantan Hospital), and Dr. Zhiyong Lou( School of Medicine, Tsinghua University) have led the R&D team and gathered a large number of outstanding PhDs and returnees. Continuous development of Anlong Bio will provide more and more jobs for society, generate more and more economic benefits, and drive the growth of the industry and surrounding areas. At the same time, it will make contributions to social responsibility and industry influence.